Influenza A H1N1 and severe asthma exacerbation

European Review for Medical and Pharmacological Sciences

Volumn 14, Issue 5, 2010, Pages 487-490

  Sposato, Bruno ^a   Croci, L ^a   Canneti, E ^a   Di Tomassi, M ^a   Migliorini, M G ^a   Ricci, A ^b   Mariotta, S ^b   Toti, M ^a  

^a MISERICORDIA HOSPITAL   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Asthma exacerbation; Influenza A H1N1; Oseltamivir; Pandemia

Indexed keywords

ANTIBIOTIC AGENT; BECLOMETASONE; BUDESONIDE; FORMOTEROL; IPRATROPIUM BROMIDE; LANSOPRAZOLE; LEVOFLOXACIN; METHYLPREDNISOLONE; MONTELUKAST; OSELTAMIVIR; OXYGEN; PANTOPRAZOLE; SALBUTAMOL; ANTIASTHMATIC AGENT; ANTIVIRUS AGENT;

ABNORMAL RESPIRATORY SOUND; ACUTE RESPIRATORY FAILURE; ADULT; ALLERGIC ASTHMA; ARTICLE; ASTHMA; BREATHING RATE; CASE REPORT; CONTINUOUS INFUSION; COUGHING; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; DYSPNEA; EMERGENCY CARE; FEMALE; FEVER; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GAS ANALYSIS; HEADACHE; HUMAN; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; MALE; NEUTROPHILIA; NOSE CONGESTION; OBESITY; OXYGEN THERAPY; PANDEMIC INFLUENZA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOKING; SORE THROAT; SPIROMETRY; SPUTUM CULTURE; WHEEZING; HOSPITALIZATION; INFLUENZA; MIDDLE AGED; PATHOPHYSIOLOGY; RESPIRATORY FAILURE; TREATMENT OUTCOME;

ADULT; ANTI-ASTHMATIC AGENTS; ANTIVIRAL AGENTS; ASTHMA; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; OSELTAMIVIR; RESPIRATORY INSUFFICIENCY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 77954630503     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. TAN WC. Viruses in asthma exacerbations. Curr Opin Pulm Med 2005; 11: 21-26.
2. GLEZEN WP. Asthma, influenza and vaccination. J Allergy Clin Immunol 2006; 118: 1199-1206.
3. EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL. Pandemic (H1N1) 2009 Update 06 November 2009, 09:00 hours CEST http://ecdc.europa.eu/en/healthtopics/ Documents/091106-Influenza-AH1N1-Situation-Report- 0900hrs.pdf. Date last updated: November 08 2009. Date last accessed: November 08, 2009.
4. JAIN S, KAMIMOTO L, BRAMLEY AM, SCHMITZ AM, BENOIT SR, LOUIE J, SUGERMAN DE, DRUCKENMILLER JK, RITGER KA, CHUGH R, JASUJA S, DEUTSCHER M, CHEN S, WALKER JD, DUCHIN JS, LETT S, SOLIVA S, WELLS EV, SWERDLOW D, UYEKI TM, FIORE AE, OLSEN SJ, FRY AM, BRIDGES CB, FINELLI L. 2009 Pandemic Influenza A (H1N1) Virus Hospitalizations Investigation Team. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009; 361: 1935-1944.
5. TREANOR JJ, HAYDEN FG, VROOMAN PS, BARBARASH R, BETTIS R, RIFF D, SINGH S, KINNERSLEY N, WARD P, MILLS RG. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group. JAMA 2000; 283: 1016-1024.
6. COOPER NJ, SUTTON AJ, ABRAMS KR, WAILOO A, TURNER D, NICHOLSON KG. Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials. Br Med J 2003; 326: 1235.
7. ROTHBERG MB, HAESSLER SD, BROWN RB. Complication of viral influenza. Am J Med 2008; 121: 258-264.
8. COSENTINI R, TARSIA P, CANETTA C, GRAZIADEI G, BRAMBILLA AM, ALIBERTI S, PAPPALETTERA M, TANTARDINI F, BLASI F. Severe asthma exacerbation: role of acute Chlamydophila pneumoniae and Mycoplasma pneumoniae infection. Respir Res 2008; 9: 48.
9. GILLISEN A. Patient's adherence in asthma. J Physiol Pharmacol 2007; 58 Suppl 5(Pt 1): 205-222.
10. CHUNG KF, CARAMORI G, ADCOCK IM. Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future. Eur J Clin Pharmacol 2009; 65: 853-871.